Why BGPT?
logo

Check Claims Before You Publish

See how your reported results read as versioned evidence records β€” linked to experiments and limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to review claims


     Quick Explanation



    Author review β€” Yuyan Liang (concise)

    Summary: the supplied author record (20 papers, 104 citations, h-index 5) shows an early-to-mid career author with modest citation impact but a heterogeneous publication record across topics (clinical, environmental, methods, engineering). Metrics suggest limited influence in mainstream biological research but some breadth; primary strengths: diverse methodology, translational/clinical topics; primary weaknesses: low citation counts per paper, unclear institutional affiliation, and variable topical focus that reduces deep domain authority. For details, see the visual author-metrics chart and full critical review below.

    Sources: author metadata provided in the request and OpenAlex matches for name disambiguation.




     Long Explanation



    Author Review β€” Yuyan Liang

    Visuals first β€” key quantitative signals (metrics, topical spread, citation distribution). Explanations follow. All claims use supplied author metadata and OpenAlex matches for context and disambiguation.

    Evidence & provenance

    1. Primary author metadata (paper list, counts, h-index=5, total citations=104) was included in the request and used to compute the metric visuals above.
    2. OpenAlex name-disambiguation matches show multiple individuals named "Yuyan Liang"; the dataset includes higher-impact profiles (e.g., Yao-Yun Liang with h-index 17) and several lower-impact profiles. This creates ambiguity when interpreting metrics for the single supplied identity β€” disambiguation risk is non-trivial and must be resolved by ORCID or institutional affiliation before strong claims about career influence are made.

    Critical analysis β€” strengths, weaknesses, blind spots

    • Strengths: Diverse topical reach (clinical reproductive health, environmental impacts, assay development, structural biology) suggests methodological flexibility and interdisciplinary capability (useful for translational or applied projects).
    • Weaknesses: Low mean citations per paper (104 citations / 20 papers = ~5.2 citations/paper) and h-index 5 indicate limited lasting impact within primary research communities; many titles are clinical or applied which sometimes attract fewer citations but also suggests lower basic-science visibility.
    • Traceability & disambiguation: No institutional affiliation or ORCID in the supplied metadata increases the chance of conflating multiple authors with similar names; OpenAlex results confirm multiple distinct profiles under this name string.
    • Topical focus: The publication list shows heterogeneous topics which can be a strength for applied work but usually slows deep accumulation of field-specific citations that build high h-indexes and central influence.
    • Potential biases to watch: Without access to full texts or author order/roles, we cannot assess relative contribution (first/last/middle author), funding sources, or conflicts of interest β€” all affect interpretation of scientific leadership.

    What evidence would shift this evaluation?

    • Definitive author disambiguation (ORCID or consistent institutional affiliation) linking these 20 papers to a single researcher would either confirm or revise metrics substantially.
    • Contribution-level data (which papers are first/last, grant PI status) would increase confidence about the author's independent scientific leadership.
    • Access to citation contexts (are the citations supportive, methodological references, or perfunctory?) would help judge scientific influence quality rather than quantity.

    Actionable recommendations

    1. Obtain and use an ORCID and ensure it is present on all publications to remove disambiguation risk.
    2. Concentrate publications in 1–2 core domains to build deeper, cumulative citation impact, and pursue review articles where appropriate (higher immediate visibility).
    3. Where possible, take first/last authorship on key works and deposit data/analysis code in public repositories to increase reuse and citations.
    4. Clarify affiliations and list consistent institutional addresses on manuscripts for better tracking and networking.
    Key provenance:

    User-supplied metrics and titles used directly for counts and topical binning; OpenAlex name-match summary used to evaluate disambiguation risk.



    Feedback:    

    Updated: March 17, 2026

     BGPT Author Review



    Scientific Quality

    40%

    Moderate/early-career impact: metrics (h-index 5, 104 citations across 20 papers) show activity but limited sustained influence; topical breadth suggests methodological flexibility but not concentrated expertise; lack of clear affiliation/orcid and low mean citations per paper are notable weaknesses.



    Communication Quality

    60%

    Paper titles are generally clear and accessible, spanning clinical and environmental topics; however, mixed topics and occasional non-English titles reduce clarity of a coherent research narrative.



    Author Novelty

    50%

    Some methodological and applied papers (e.g., assay development, structural inhibitor studies) show novel technical work, but majority of publications are applied/descriptive, leading to moderate novelty overall.



    Scientific Rigor

    50%

    Insufficient metadata to fully evaluate methods, author roles, or reproducibility indicators; mix of clinical cross-sectional studies, structural X-ray work, and methods papers suggests variable rigor across outputs.

     Science Art


    Author Review: Yuyan Liang Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT